Amy Huberman

Statistics

Publications

Citations

257

H-Index

Active since

1984

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Amy Huberman is an author at Roswell Park Comprehensive Cancer Center specializing in oncology, combination chemotherapy, and hematologic malignancy therapy.

Publications per year

1984–2003

Publications

Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.

Francisco J. Hernandez‐Ilizaliturri, Venkata Jupudy, Julie R. Ostberg et al. · PubMed · 2003 · 190 citations

Life Sciences, Immunology, Oncology +15

An update of two randomized trials in previously untreated multiple myeloma comparing melphalan and prednisone versus three- and five-drug combinations: an Argentine Group for the Treatment of Acute Leukemia Study.

S Pavlovsky, Claudia Corrado, M Santarelli et al. · Journal of Clinical Oncology · 1988 · 35 citations

Medicine, Oncology, Pharmacotherapy +16

A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.

S Pavlovsky, J Saslavsky, Manuel Pinto et al. · Journal of Clinical Oncology · 1984 · 32 citations

Medicine, Oncology, Pharmacotherapy +13

1–3 of 3